Pilot Study Evaluating Feasibility and Benefits of Telemonitored NIV Treatment on COPD Patients (eCOPD)
Status
Conditions
Treatments
Details and patient eligibility
About
Pilot study evaluating feasibility and benefits of telemonitored NIV (noninvasive ventilation) treatment on COPD (chronic obstructive pulmonary disease) patients.
Multicentric Randomized Controlled Trial
Primary Objective:
To evaluate benefits of telemonitoring system, Easy Care Online (ECO), on NIV long term treatment efficacy and patient compliance
Secondary Objectives:
To determine predictive factors of COPD exacerbation in patients treated by NIV with ECO To carry out a health economic evaluation on telemonitoring benefits in COPD pts treated with NIV
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- COPD patient already treated by NIV requiring therapy assessment in their routine care Follow-Up or
- COPD patient requiring de Novo NIV therapy according to routine care rules (NIV<12h)
- Patient requiring NIV therapy by S9 VPAP ST +/- oxygen therapy
- Patient willing to participate to the study
- Patient or attendant able to complete patient passport and to come to Follow-Up visits.
Exclusion criteria
- NIV therapy Failure during screening phase (intolerance, patient refusal, significant leaks, significant AHI or Oxymetry events)
- Hospitalization conducting to NIV discontinuation for at least 1 week during the screening phase
Trial design
Primary purpose
Allocation
Interventional model
Masking
20 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal